Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial.

Shaakir Hasan,Stanislav Lazarev,Madhur Garg,Rachel Gozland,John Chang,William Hartsell,Jonathan Chen,Henry Tsai,Carlos Vargas,Charles B Simone,Daniel Gorovets

The Prostate（2023）

引用 0|浏览8

暂无评分

摘要

In the largest series published to date, our results suggest early outcomes using proton therapy for HRPC are encouraging for both safety and efficacy. Further evaluation is needed to determine if an advantage exists to use protons over other radiation techniques in this population.

查看译文

关键词

high risk,prostate cancer,proton

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要